Paper39167378
Light Therapy for Myopia Prevention and Control: A Systematic Review on Effectiveness, Safety, and Implementation.
Chang DJ and 5 others. Transl Vis Sci Technol, 2024. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Light Therapy for Myopia Prevention and Control: A Systematic Review on Effectiveness, Safety, and Implementation. Papers, record 39167378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39167378
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Light Therapy for Myopia Prevention and Control: A Systematic Review on Effectiveness, Safety, and Implementation.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myopia | Major topic |
| Humans | |
| Child | |
| Phototherapy | |
| Refraction, Ocular | |
| Treatment Outcome |
Source PubMed
References96
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31722876 | How does spending time outdoors protect against myopia? A review. | Br J Ophthalmol | 2020 | https://conductscience.org/library/papers/31722876 | PubMed |
| 2 | 38297353 | The influence of the environment and lifestyle on myopia. | J Physiol Anthropol | 2024 | https://conductscience.org/library/papers/38297353 | PubMed |
| 3 | 35067020 | Effect of Classroom Illuminance on the Development and Progression of Myopia in School Children. | Korean J Ophthalmol | 2022 | https://conductscience.org/library/papers/35067020 | PubMed |
| 4 | 31462531 | RoB 2: a revised tool for assessing risk of bias in randomised trials. | BMJ | 2019 | https://conductscience.org/library/papers/31462531 | PubMed |
| 5 | 34142457 | Near work, screen time, outdoor time and myopia in schoolchildren in the Sunflower Myopia AEEC Consortium. | Acta Ophthalmol | 2022 | https://conductscience.org/library/papers/34142457 | PubMed |
| 6 | 37024437 | Low-Power Red Laser Treatment for Anisometropic Myopia Control in Children: A Contralateral Comparison Study. | Discov Med | 2023 | https://conductscience.org/library/papers/37024437 | PubMed |
| 7 | 34981548 | Low-intensity, long-wavelength red light slows the progression of myopia in children: an Eastern China-based cohort. | Ophthalmic Physiol Opt | 2022 | https://conductscience.org/library/papers/34981548 | PubMed |
| 8 | 36609829 | Clinically Significant Axial Shortening in Myopic Children After Repeated Low-Level Red Light Therapy: A Retrospective Multicenter Analysis. | Ophthalmol Ther | 2023 | https://conductscience.org/library/papers/36609829 | PubMed |
| 9 | 33575355 | Orthokeratology and Low-Intensity Laser Therapy for Slowing the Progression of Myopia in Children. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/33575355 | PubMed |
| 10 | 37444391 | Skin Cancer Risk, Sun-Protection Knowledge and Behavior in Athletes-A Narrative Review. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37444391 | PubMed |
| 11 | 31106030 | Outdoor Jogging and Myopia Progression in School Children From Rural Beijing: The Beijing Children Eye Study. | Transl Vis Sci Technol | 2019 | https://conductscience.org/library/papers/31106030 | PubMed |
| 12 | 32940622 | Association of Age at Myopia Onset With Risk of High Myopia in Adulthood in a 12-Year Follow-up of a Chinese Cohort. | JAMA Ophthalmol | 2020 | https://conductscience.org/library/papers/32940622 | PubMed |
| 13 | 36294321 | Short-Term Exposure to Violet Light Emitted from Eyeglass Frames in Myopic Children: A Randomized Pilot Clinical Trial. | J Clin Med | 2022 | https://conductscience.org/library/papers/36294321 | PubMed |
| 14 | 35911574 | Outdoor activities and sunburn among urban and rural families in a Western region of the US: Implications for skin cancer prevention. | Prev Med Rep | 2022 | https://conductscience.org/library/papers/35911574 | PubMed |
| 15 | 35893353 | A Cross-Sectional Observational Study of the Relationship between Outdoor Exposure and Myopia in University Students, Measured by Conjunctival Ultraviolet Autofluorescence (CUVAF). | J Clin Med | 2022 | https://conductscience.org/library/papers/35893353 | PubMed |
| 16 | 30956032 | Effects of irradiance on UVA-induced skin aging. | J Dermatol Sci | 2019 | https://conductscience.org/library/papers/30956032 | PubMed |
| 17 | 36054314 | Sustained and rebound effect of repeated low-level red-light therapy on myopia control: A 2-year post-trial follow-up study. | Clin Exp Ophthalmol | 2022 | https://conductscience.org/library/papers/36054314 | PubMed |
| 18 | 33782057 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. | BMJ | 2021 | https://conductscience.org/library/papers/33782057 | PubMed |
| 19 | 28448513 | Outdoor activity and myopia progression in 4-year follow-up of Chinese primary school children: The Beijing Children Eye Study. | PLoS One | 2017 | https://conductscience.org/library/papers/28448513 | PubMed |
| 20 | 33961969 | The Risks and Benefits of Myopia Control. | Ophthalmology | 2021 | https://conductscience.org/library/papers/33961969 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42623386 | Spectral characteristics of light and their association with myopia progression in children: A systematic review protocol. | PLoS One | 2026 | https://conductscience.org/library/papers/42623386 | PubMed |
| 42366310 | Myopia management functional lenses (MMFL): a bibliometric analysis of multidisciplinary perspective and trend insights in the context of vision health. | Int Ophthalmol | 2026 | https://conductscience.org/library/papers/42366310 | PubMed |
| 42007653 | Ocular Transmission of Red and Violet Light: Insights into Light-Based Myopia Therapies. | Transl Vis Sci Technol | 2026 | https://conductscience.org/library/papers/42007653 | PubMed |
| 41973380 | Current Evidence on Options and Efficacy of Combination Therapy for Myopia Control-A Narrative Review. | Ophthalmic Physiol Opt | 2026 | https://conductscience.org/library/papers/41973380 | PubMed |
| 41262727 | Awareness of Myopia Associated Complications and Perspectives on Myopia Management Among Parents of Children with Myopia in France and the UK. | Patient Relat Outcome Meas | 2025 | https://conductscience.org/library/papers/41262727 | PubMed |
| 40960225 | IMI-Interventions for Controlling Myopia Onset and Progression 2025. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40960225 | PubMed |
| 40414624 | Peripheral retinal irradiation with low-energy red light can effectively and safely delay the progression of myopia. | BMJ Open Ophthalmol | 2025 | https://conductscience.org/library/papers/40414624 | PubMed |
| 40012065 | Lifestyle and sleep-related behaviours in children with myopia. | BMC Ophthalmol | 2025 | https://conductscience.org/library/papers/40012065 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39167378
GET https://conductscience.org/api/papers/v1/39167378/references?page=2